Personal care company Edgewell Personal Care (NYSE:EPC) missed Wall Street’s revenue expectations in Q2 CY2026 as sales only rose 1.7% year on year to $570.1 million. Its non-GAAP profit of $0.72 per share was 17.6% above analysts’ consensus estimates.
Is now the time to buy Edgewell Personal Care? Find out by accessing our full research report, it’s free.
Edgewell Personal Care (EPC) Q2 CY2026 Highlights:
- Revenue: $570.1 million vs analyst estimates of $577.1 million (1.7% year-on-year growth, 1.2% miss)
- Adjusted EPS: $0.72 vs analyst estimates of $0.61 (17.6% beat)
- Adjusted EBITDA: $78.9 million vs analyst estimates of $72.89 million (13.8% margin, 8.2% beat)
- Adjusted EPS guidance for the full year is $1.90 at the midpoint, beating analyst estimates by 0.6%
- EBITDA guidance for the full year is $255 million at the midpoint, above analyst estimates of $252.7 million
- Operating Margin: 4.4%, down from 8% in the same quarter last year
- Organic Revenue rose 1.1% year on year (miss)
- Market Capitalization: $1.31 billion
"Our third quarter results represent an important step forward in our fiscal 2026 progression, with organic net sales returning to growth, meaningful improvement in North America, and adjusted EPS and adjusted EBITDA ahead of expectations," said Rod Little, Edgewell's President and Chief Executive Officer.
Company Overview
Boasting brands such as Banana Boat, Schick, and Skintimate, Edgewell Personal Care (NYSE:EPC) sells personal care products in the skin and sun care, shave, and feminine care categories.
Revenue Growth
Examining a company’s long-term performance can provide clues about its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul.
With $1.98 billion in revenue over the past 12 months, Edgewell Personal Care is a small consumer staples company, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and negotiating leverage with retailers.
As you can see below, Edgewell Personal Care’s revenue declined by 4.2% per year over the last three years, a rough starting point for our analysis.
This quarter, Edgewell Personal Care’s revenue grew by 1.7% year on year to $570.1 million, falling short of Wall Street’s estimates.
Looking ahead, sell-side analysts expect revenue to grow 1.8% over the next 12 months. While this projection suggests its newer products will catalyze better top-line performance, it is still below the sector average.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
Organic Revenue Growth
When analyzing revenue growth, we care most about organic revenue growth. This metric captures a business’s performance excluding one-time events such as mergers, acquisitions, and divestitures as well as foreign currency fluctuations.
Edgewell Personal Care’s demand has been falling over the last eight quarters, and on average, its organic sales have declined by 1.1% year on year. 
In the latest quarter, Edgewell Personal Care’s organic sales rose by 1.1% year on year. This growth was a well-appreciated turnaround from its historical levels, showing the business is regaining momentum.
Key Takeaways from Edgewell Personal Care’s Q2 Results
We were impressed by how significantly Edgewell Personal Care blew past analysts’ EBITDA expectations this quarter. We were also glad its EPS outperformed Wall Street’s estimates. On the other hand, its organic revenue missed and its gross margin fell short of Wall Street’s estimates. Zooming out, we think this was a mixed quarter. The stock remained flat at $28.57 immediately after reporting.
Should you buy the stock or not? If you’re making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here (it’s free).